@RaceOncology Hey T, Are you familiar with SGLT2 inhibitors? . Are they our competition and if so, is this a concern? Thanks
@Boffin99 This article talks all about SGLT2 inhibitors MOA. Interestingly its primary use is for diabetics. Should be a good read for you.
https://www.sciencedirect.com/science/article/pii/S2666087324000486
Cardioprotection thread, page-556
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.030(2.11%) |
Mkt cap ! $247.1M | |||
| Open | High | Low | Value | Volume |
| $1.43 | $1.45 | $1.40 | $163.8K | 115.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 31396 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| RAC (ASX) Chart |